INS and type 2 diabetes mellitus: We combined network pharmacology and molecular docking to predict key targets, followed by in vitro experiments in insulin‐resistant cells and in vivo validation in a T2DM mouse model (high‐fat diet and STZ‐induced), thus providing novel mechanistic insights for the nutritional application of sinapine in T2DM management.